Back to Products & Projects
AI ProductsContent StrategyPlatformsDatabase Management

Drug-Drug & Drug-Lifestyle Interaction Engine

  • Scoped and led the end-to-end build of a drug-drug interaction (DDI) and drug-lifestyle interaction (DLI) database, covering alcohol, tobacco, and food as lifestyle parameters.
  • The tool enables multi product interaction checks with severity grading (life-threatening, severe, moderate, mild, no interaction), layered explanations, and user-facing action recommendations.
  • Collaborated with teams to define schema, severity logic, consume-type mapping, and front end display architecture.
  • Extended the database to cover oncology-specific interactions in partnership with Tata Memorial Centre (TMC), handling anti cancer drug interactions as a distinct, regulated category.

The Challenge

  • No standardised interaction database existed internally.
  • Over 5.5 lakh raw interactions from various sources needed to be cleaned, classified and mapped to Tata 1MG's internal drug IDs across drugs and products.
  • FDC (fixed-dose combination) interactions required a novel logic framework, as standard interaction tools do not account for combination drug behaviour.
  • Oncology drug interactions required a separate pipeline due to their high risk, highly specific nature and the involvement of an external hospital partner.

The Approach

  • Used Python and BeautifulSoup4 to scrape and structure data across 5.5 lakh interaction entries, building a phased delivery pipeline across severity tiers.
  • Designed a consume type level mapping system to enable interaction checks at the granular drug-form level, not just the salt level.
  • Built interaction libraries for red (life-threatening/severe), yellow (moderate), blue (mild), and green (no interaction) categories, each with severity grading, explanations, and layman friendly action text.
  • Led reference mapping for ~2 lakh DDI entries and ~1,000 DLI entries to anchor every interaction to a citable clinical source.
  • Collaborated with the Tata Memorial Centre to isolate and deliver 4 batches of oncology-specific interactions (~31,000 interactions) with specialised validation.
  • Licensed the DDI tool to Samsung Health as part of a $175,000 commercial partnership, covering 2 lakh interactions across 5 lakh+ product combinations.

Results

2 lakh+ drug drug interactions
31,000+ anti-cancer interactions
1000+ drug lifestyle interactions
DDI tool licensed to Samsung Health as part of a $175,000 commercial integration.
Post launch 95% accuracy established

Tech Stack

PythonBeautifulSoup4PandasInternal CMSConfluence

Have a similar project?

Let's discuss how we can help bring your vision to life.

Start a Conversation